First Time Loading...

Lilycolor Co Ltd
TSE:9827

Watchlist Manager
Lilycolor Co Ltd Logo
Lilycolor Co Ltd
TSE:9827
Watchlist
Price: 736 JPY -2.65% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

20.2B
-4%
Assets
Growth Rates:
1 Year
-4%
3 Years
+6%
5 Years
+6%
7 Years
+4%
10 Years
+1%
11.6B
-7%
Liabilities
Growth Rates:
1 Year
-13%
3 Years
-7%
5 Years
-10%
7 Years
-11%
10 Years
-17%
8.5B
+1%
Equity
Growth Rates:
1 Year
+11%
3 Years
+33%
5 Years
+40%
7 Years
+34%
10 Years
+46%

Balance Sheet Decomposition
Lilycolor Co Ltd

20.2B
Assets
11.6B
Liabilities
20.2B
Assets
11.6B
Liabilities
Current Assets 16B
Cash & Short-Term Investments 2.8B
Receivables 9.1B
Other Current Assets 4.1B
Non-Current Assets 4.2B
Long-Term Investments 461.2m
PP&E 1.5B
Intangibles 315.6m
Other Non-Current Assets 1.9B
Current Liabilities 10.5B
Accounts Payable 8.1B
Accrued Liabilities 639.7m
Short-Term Debt 334.7m
Other Current Liabilities 1.4B
Non-Current Liabilities 1.1B
Long-Term Debt 850.8m
Other Non-Current Liabilities 297.1m

Balance Sheet
Lilycolor Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
4 599
5 384
3 596
3 966
2 139
3 369
2 908
4 015
2 356
2 805
Cash Equivalents
4 599
5 384
3 596
3 966
2 139
3 369
2 908
4 015
2 356
2 805
Total Receivables
7 212
6 977
7 722
6 405
8 775
8 462
8 667
7 981
11 016
9 074
Accounts Receivables
4 766
4 850
5 055
4 567
6 095
6 169
6 479
6 153
8 590
7 021
Other Receivables
2 446
2 127
2 667
1 838
2 680
2 293
2 188
1 828
2 425
2 053
Inventory
2 501
2 395
2 500
2 540
2 691
2 580
2 468
2 584
3 003
3 495
Other Current Assets
27
790
835
640
763
713
566
589
538
638
Total Current Assets
14 871
15 545
14 652
13 551
14 369
15 124
14 609
15 168
16 912
16 012
PP&E Net
1 615
1 575
1 528
1 343
1 268
1 363
1 328
1 312
1 324
1 469
PP&E Gross
1 615
1 575
1 528
1 343
1 268
1 363
1 328
1 312
1 324
1 469
Accumulated Depreciation
0
2 922
3 000
3 034
2 952
2 938
2 970
2 983
3 028
2 950
Intangible Assets
257
169
114
38
92
246
257
331
375
316
Note Receivable
0
99
104
66
92
107
107
72
77
78
Long-Term Investments
0
567
325
386
341
338
275
322
359
461
Other Long-Term Assets
2 713
2 551
2 683
2 775
2 852
2 235
2 373
1 880
2 048
1 834
Total Assets
20 070
N/A
20 507
+2%
19 407
-5%
18 158
-6%
19 013
+5%
19 413
+2%
18 949
-2%
19 085
+1%
21 095
+11%
20 170
-4%
Liabilities
Accounts Payable
9 471
9 488
9 219
8 727
9 811
9 447
8 697
8 646
8 486
8 100
Accrued Liabilities
273
374
372
361
249
520
404
496
791
640
Short-Term Debt
354
380
234
274
424
427
389
376
388
335
Current Portion of Long-Term Debt
923
974
870
640
625
493
654
603
640
614
Other Current Liabilities
841
969
659
618
711
720
538
639
1 722
795
Total Current Liabilities
11 861
12 185
11 354
10 620
11 821
11 606
10 682
10 759
12 027
10 483
Long-Term Debt
1 788
1 420
1 198
1 027
715
962
1 494
1 235
1 061
851
Deferred Income Tax
0
68
12
0
0
0
0
0
0
0
Other Liabilities
474
457
451
412
376
356
355
312
299
297
Total Liabilities
14 182
N/A
14 131
0%
13 015
-8%
12 058
-7%
12 912
+7%
12 924
+0%
12 531
-3%
12 306
-2%
13 387
+9%
11 631
-13%
Equity
Common Stock
3 336
3 336
3 336
3 336
3 336
3 336
3 336
3 336
3 336
3 336
Retained Earnings
122
544
671
343
383
770
740
1 069
1 957
2 708
Additional Paid In Capital
2 363
2 363
2 363
2 363
2 363
2 363
2 363
2 363
2 363
2 363
Unrealized Security Profit/Loss
127
195
82
119
80
81
40
73
114
193
Treasury Stock
60
60
60
60
61
61
61
61
61
61
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
5 888
N/A
6 376
+8%
6 391
+0%
6 100
-5%
6 101
+0%
6 489
+6%
6 418
-1%
6 779
+6%
7 708
+14%
8 539
+11%
Total Liabilities & Equity
20 070
N/A
20 507
+2%
19 407
-5%
18 158
-6%
19 013
+5%
19 413
+2%
18 949
-2%
19 085
+1%
21 095
+11%
20 170
-4%
Shares Outstanding
Common Shares Outstanding
12
12
12
12
12
12
12
12
12
12

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.